| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5900065 | Diabetes Research and Clinical Practice | 2011 | 10 Pages |
Abstract
Co-induction of DM and HCC increased liver tissue lesion, serum AFP, ES, liver AR and SDH. Co-administration of DAS/AA reduced ES, AR without changing SDH. DAS/AA co-therapy lowered ES by depressing AR without affecting SDH, meaning that AR is activated by cancer and DM in different ways. PP is early marker for HCC detection and response to chemoprevention. DAS/AA combination is promising cost effective chemopreventive and anti-diabetic combination.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
N.M. Abdel-Hamid, M.H. Nazmy, A.I. Abdel-Bakey,